CTEV
Q3 2026 EPS Estimate
$-4.10
Aug 5, 2026 · Reports before open
Revenue Estimate
$245M

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
69
Score
3 Buy (75%)1 Hold (25%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
375%
Hold
125%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$28.00
-17.2%
Consensus
$34.00
+0.6%
Bull
$61.00
+80.4%
12-Month Target Range4 analysts
$28.00$34.00$61.00
Current $33.81Consensus
Current Price
$33.81
Upside to Consensus
$0.19

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.51%
EPS
FY2028
Rev+3.97%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$993M$1.04B$1.08B
Low$990M$1.04B$1.08B
High$998M$1.04B$1.08B
EBITDA Avg$208M$217M$226M
Low$207M$217M$226M
High$209M$218M$226M
EBIT Avg$-122M$-128M$-133M
Low$-123M$-128M$-133M
High$-122M$-127M$-133M
Net Income Avg$-262M$-228M$-229M
Low$-263M$-229M$-246M
High$-261M$-227M$-187M
EPS Avg$-15.93$-13.87$-13.05
Low$-16.01$-13.95$-14.98
High$-15.87$-13.82$-11.37
Analysts (Rev / EPS)3 / 23 / 24 / 4
Quarterly
MetricQ2 2026Q3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$245M$250M$254M$256M$258M$261M$266M
Low$244M$248M$252M$255M$256M$259M$265M
High$246M$251M$255M$257M$259M$262M$268M
EBITDA Avg$51M$52M$53M$54M$54M$55M$56M
Low$51M$52M$53M$53M$54M$54M$55M
High$52M$53M$53M$54M$54M$55M$56M
EBIT Avg$-30M$-31M$-31M$-31M$-32M$-32M$-33M
Low$-30M$-31M$-31M$-32M$-32M$-32M$-33M
High$-30M$-31M$-31M$-31M$-32M$-32M$-33M
Net Income Avg$-69M$-64M$-61M$-63M$-62M$-59M$-56M
Low$-69M$-65M$-62M$-63M$-62M$-59M$-57M
High$-68M$-64M$-61M$-62M$-62M$-58M$-56M
EPS Avg$-4.12$-3.86$-3.68$-3.75$-3.71$-3.50$-3.38
Low$-4.15$-3.89$-3.70$-3.78$-3.74$-3.53$-3.40
High$-4.10$-3.83$-3.65$-3.73$-3.69$-3.48$-3.35
Analysts (Rev / EPS)3 / 12 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jun 3, 2026Piper Sandler
Claritev price target lowered to $61 from $90 at Piper Sandler
Target:$61.00
+144.0%from $25.00
Apr 24, 2026Barclays
Claritev initiated with an Overweight at Barclays
Target:$28.00
+37.9%from $20.30
Feb 24, 2026Wells Fargo
Claritev price target lowered to $30 from $33 at Wells Fargo
Target:$30.00
+29.1%from $23.23
Feb 24, 2026Guggenheim
Claritev price target lowered to $38 from $43 at Guggenheim
Target:$38.00
+63.6%from $23.23
Jan 8, 2026Wells Fargo
Claritev initiated with an Equal Weight at Wells Fargo
Target:$33.00
+5.7%from $31.21
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.